On the Radar
Federal office upholds UW’s stem cell patent
Looking for a print version?
Simply choose ‘Print’ on your computer and a printer-friendly document will be generated.
Also by Nick Penzenstadler:
- UW cancels classes; food service closes early; Metro to shut down at 7 p.m. (February 6, 2008)
Related Stories:
- UW re-opens Thursday after Wednesday's snowstorm (February 7, 2008)
- Chelsea Clinton scheduled to speak in Madison Monday (February 10, 2008)
- UW cancels today's classes in Van Vleck (March 3, 2008)
- UW cancels classes today in Van Vleck (March 3, 2008)
- Bill Clinton in Madison on Thursday (February 12, 2008)
by Nick Penzenstadler
Thursday, February 28, 2008
The University of Wisconsin’s main patent arm’s Wisconsin Alumni Research Foundation announced Thursday morning they were notified of a key trademark decision in their favor.
The United States Patent and Trademark’s Office ruled to uphold the Wisconsin Alumni Research Foundation’s claims in the face of New York and California based biotech organizations that challenged the patent’s validity in 2006.
WARF’s managing director Carl Gulbrandsen said in a statement Thursday the decision coincided with what they had always maintained since 1998.
“We’re extremely pleased with this decision,” Gulbrandsen said. “It affirms what WARF has believed all along, that Dr. Thomson’s breakthrough discoveries are patentable inventions.”
The patent, “913,” deals with primate and human embryonic stem cells. Two other patents, numbers “780” and “806” are still pending a review by the trademark office.
See more about the future of UW’s stem cell patents in Friday’s edition of The Badger Herald.
